Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-31 @ 3:56 AM
Study NCT ID:
NCT07361705
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-01-23
First Post:
2025-12-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Zorifertinib With Osimertinib for NSCLC With Meningeal Progression
Sponsor:
Alpha Biopharma (Jiangsu) Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-01-31
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-04-23
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-09-15
Completion Date Type:
ESTIMATED
First Submit Date:
2025-12-04
First Submit QC Date:
None
Study First Post Date:
2026-01-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-01-15
Last Update Post Date:
2026-01-23
Last Update Post Date Type:
ACTUAL